TPTX » Topics » C. Aggregate Option Exercises in Fiscal Year 2004 Year End Option Values

This excerpt taken from the TPTX DEF 14A filed May 17, 2005.

C.            Aggregate Option Exercises in Fiscal Year 2004 Year End Option Values

                The following table sets forth the number and value of unexercised options held by the Named Executive Officers as of December 31, 2004.

 

Number of
shares acquired
on exercise
Value ($)
Realized
Number of
securities
underlying
unexercised
options
at fiscal year
end #(1)
Value of
unexercised in-the-
money options at
fiscal year end ($)
(2)

Name Exercisable/
unexercisable
Exercisable/
unexercisable

 
Marvin S. Hausman,   175,000   $ 845,000     562,500/   $ 769,875/  
M.D., Chairman & CEO (3)               362,500   $ 815,875  
                         
Gosse B. Bruinsma,   215,000   $ 1,064,000     435,000/   $ 699,900/  
M.D., Pres. & COO (3)               290,000   $ 846,850  
                         
S. Colin Neill, C.F.O           117,500/   $ 256,950/  
              142,500   $ 256,950  

18



  (1)
The number of options granted for certain Executive Officers in 2003 have been adjusted to include options granted in 2003 under our 2000 Stock Option Plan which were contingent upon the January 1, 2004 increase in the number of shares reserved for issuance under the 2000 Stock Option Plan by 750,000 shares per the evergreen provision. The increase in options granted for each Executive Officer in 2003 due to this adjustment are as follows: Marvin S. Hausman, M.D. 125,000; Gosse B. Bruinsma, M.D. 100,000; S. Colin Neill 93,620.
     
  (2)
Dollar amounts reflect the net values of outstanding stock options computed as the difference between $6.20 (the fair market value at December 31, 2004) and the exercise price of the options.
     
  (3)
Dr. Bruinsma replaced Dr. Hausman as CEO effective March 3, 2005.
 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki